Related Experiment Video
Updated: May 10, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease
Dimitrios Poulikakos1, Louise Ross, Alejandro Recio-Mayoral
1Renal and Transplantation Unit, St George's Healthcare NHS Trust, Blackshaw Road, Tooting, London SW19 8TN, UK.
European Heart Journal. Cardiovascular Imaging
|July 2, 2013
Summary
Endothelial dysfunction (ED) is linked to left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD). This pilot study suggests ED may contribute to LVH in non-dialysis CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- High mortality in chronic kidney disease (CKD) is often due to cardiovascular events.
- Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality in CKD patients.
- Vascular endothelial dysfunction (ED) is prevalent in CKD, but its role in LVH among non-dialysis patients is unclear.
Purpose of the Study:
- To investigate the association between endothelial dysfunction (ED) and left ventricular hypertrophy (LVH) in patients with non-dialysis chronic kidney disease (CKD).
Main Methods:
- The study included 30 non-dialysis CKD patients and 29 controls.
- Measurements included high-sensitivity C-reactive protein (hsCRP), systemic ED via brachial artery flow-mediated dilatation (FMD), and LVH assessed by echocardiography.
- Left ventricular mass index (LVMI) was calculated and indexed by height.
Main Results:
- CKD patients exhibited higher hsCRP, reduced FMD, and increased LVMI compared to controls.
- A significant inverse correlation was found between LVMI and FMD in CKD patients (r = -0.371; P = 0.043).
- LVMI was significantly higher in CKD patients with low FMD (<2.3%) compared to those with FMD ≥2.3% (P = 0.033).
Conclusions:
- This pilot study reveals a significant association between endothelial dysfunction (ED) and left ventricular hypertrophy (LVH) in non-dialysis CKD patients.
- The findings suggest a potential causal link between ED and LVH in this population.
- Further research is warranted to confirm the cause-effect relationship.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...